|
1
|
Ekiz F, Ormeci N, Coban S, et al:
Association of methylenetetrahydrofolate reductase C677T-A1298C
polymorphisms with risk for esophageal adenocarcinoma, Barrett’s
esophagus, and reflux esophagitis. Dis Esophagus. Sep 23–2011.(Epub
ahead of print).
|
|
2
|
Yoon HH, Khan M, Shi Q, et al: The
prognostic value of clinical and pathologic factors in esophageal
adenocarcinoma: a Mayo cohort of 796 patients with extended
follow-up after surgical resection. Mayo Clin Proc. 85:1080–1089.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bor S, Vardar R, Ormeci N, et al:
Prevalence patterns of gastric cancers in Turkey: model of a
developing country with high occurrence of Helicobacter
pylori. J Gastroenterol Hepatol. 22:2242–2245. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reavis KM, Morris CD, Gopal DV, Hunter JG
and Jobe BA: Laryngopharyngeal reflux symptoms better predict the
presence of esophageal adenocarcinoma than typical gastroesophageal
reflux symptoms. Ann Surg. 239:849–856. 2004. View Article : Google Scholar
|
|
5
|
Das A: Tumors of the Esophagus. In:
Sleisenger and Fordtran’s Gastrointestinal and Liver Disease.
Feldman M, Friedman L, Friedman S and Brandt JL: Saunders,
Elsevier; Philadelphia: pp. 745–773. 2010
|
|
6
|
Zendehdel N, Biramijamal F, Hossein-Nezhad
A, Zendehdel N, Sarie H, Doughaiemoghaddam M and Pourshams A: Role
of cytochrome P450 2C19 genetic polymorphisms in the therapeutic
efficacy of omeprazole in Iranian patients with erosive reflux
esophagitis. Arch Iran Med. 13:406–412. 2010.PubMed/NCBI
|
|
7
|
Bayrakçi B, Kasap E, Kitapçioğlu G and Bor
S: Low prevalence of erosive esophagitis and Barrett esophagus in a
tertiary referral center in Turkey. Turk J Gastroenterol.
19:145–151. 2008.PubMed/NCBI
|
|
8
|
Bor S, Mandıracıoglu A, Kitapcıoglu G,
Caymaz-Bor C and Gilbert RJ: Gastroesophageal reflux in a
low-income region in Turkey. Am J Gastroenterol. 100:744–754.
2005.PubMed/NCBI
|
|
9
|
Peng D, Hu TL, Jiang A, Washington MK,
Moskaluk CA, Schneider-Stock R and El-Rifai W: Location-specific
epigenetic regulation of the metallothionein 3 gene in esophageal
adenocarcinomas. PLoS One. 6:e220092011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sharma S, Kelly TK and Jones PA:
Epigenetics in cancer. Carcinogenesis. 31:27–36. 2010. View Article : Google Scholar
|
|
11
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
12
|
Jones PA and Baylin SBl: The epigenomics
of cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feinberg AP, Ohlsson R and Henikoff S: The
epigenetic progenitor origin of human cancer. Nat Rev Genet.
7:21–33. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoo CB and Jones PA: Epigenetic therapy of
cancer: past, present and future. Nat Rev Drug Discov. 5:37–50.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lundell LR, Dent J, Bennett JR, et al:
Endoscopic assessment of oesophagitis: clinical and functional
correlates and further validation of the Los Angeles
classification. Gut. 45:172–180. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Egger G, Liang G, Aparicio A and Jones PA:
Epigenetics in human disease and prospects for epigenetic therapy.
Nature. 429:457–463. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tzao C, Tung HJ, Jin JS, et al: Prognostic
significance of global histone modifications in resected squamous
cell carcinoma of the esophagus. Mod Pathol. 22:252–260. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao X, Xia Y, Yang J, et al: Clinical and
biological significance of never in mitosis gene A-related kinase 6
(NEK6) expression in hepatic cell cancer. Pathol Oncol Res.
18:201–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Malumbres M and Barbacid M: Cell cycle
kinases in cancer. Curr Opin Genet Dev. 17:60–65. 2007. View Article : Google Scholar
|
|
20
|
Fu J, Bian M, Jiang Q and Zhang C: Roles
of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res.
5:1–10. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moniz L, Dutt P, Haider N and Stambolic V:
Nek family of kinases in cell cycle, checkpoint control and cancer.
Cell Div. 6:182011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sen S, Zhou H and White RA: A putative
serine/threonine kinase encoding gene BTAK on chromosome 20q13 is
amplified and overexpressed in human breast cancer cell lines.
Oncogene. 14:2195–2200. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Reiter R, Gais P, Jütting U, et al: Aurora
kinase A messenger RNA overexpression is correlated with tumor
progression and shortened survival in head and neck squamous cell
carcinoma. Clin Cancer Res. 12:5136–5141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rugge M, Fassan M, Zaninotto G, et al:
Aurora kinase A in Barrett’s carcinogenesis. Hum Pathol.
41:1380–1386. 2010.
|
|
25
|
Lo Iacono M, Monica V, Saviozzi S, Ceppi
P, Bracco E, Papotti M and Scagliotti GV: Aurora Kinase A
expression is associated with lung cancer histological-subtypes and
with tumor de-differentiation. J Transl Med. 9:1002011.PubMed/NCBI
|
|
26
|
Sillars-Hardebol AH, Carvalho B, de Wit M,
et al: Identification of key genes for carcinogenic pathways
associated with colorectal adenoma-to-carcinoma progression. Tumour
Biol. 31:89–96. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dar AA, Zaika A, Piazuelo MB, et al:
Frequent overexpression of Aurora Kinase A in upper
gastrointestinal adenocarcinomas correlates with potent
antiapoptotic functions. Cancer. 112:1688–1698. 2008. View Article : Google Scholar
|
|
28
|
El-Rifai W and Powell SM: Molecular and
biologic basis of upper gastrointestinal malignancy. Gastric
carcinoma. Surg Oncol Clin N Am. 11:273–291. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shaheen N and Ransohoff DF:
Gastroesophageal reflux, Barrett esophagus, and esophageal cancer:
scientific review. JAMA. 287:1972–1981. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jee HJ, Kim AJ, Song N, Kim HJ, Kim M, Koh
H and Yun J: Nek6 overexpression antagonizes p53-induced senescence
in human cancer cells. Cell Cycle. 9:4703–4710. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yin MJ, Shao L, Voehringer D, Smeal T and
Jallal B: The serine/threonine kinase Nek6 is required for cell
cycle progression through mitosis. J Biol Chem. 278:52454–52460.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Belham C, Roig J, Caldwell JA, Aoyama Y,
Kemp BE, Comb M and Avruch J: A mitotic cascade of NIMA family
kinases. Nercc1/Nek9 activates the Nek6 and Nek7 kinases. J Biol
Chem. 278:34897–34909. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
O’Regan L and Fry AM: The Nek6 and Nek7
protein kinases are required for robust mitotic spindle formation
and cytokinesis. Mol Cell Biol. 29:3975–3990. 2009.PubMed/NCBI
|
|
34
|
Nassirpour R, Shao L, Flanagan P, Abrams
T, Jallal B, Smeal T and Yin MJ: Nek6 mediates human cancer cell
transformation and is a potential cancer therapeutic target. Mol
Cancer Res. 8:717–728. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Takeno A, Takemasa I, Doki Y, et al:
Integrative approach for differentially overexpressed genes in
gastric cancer by combining largescale gene expression profiling
and network analysis. Br J Cancer. 99:1307–1315. 2008. View Article : Google Scholar
|
|
36
|
Lagergren J: Increased incidence of
adenocarcinoma of the esophagus and cardia. Reflux and obesity are
strong and independent risk factors according to the SECC study.
Lakartidningen J. 97:1950–1953. 2000.(In Swedish).
|
|
37
|
Erichsen R, Robertson D, Farkas DK,
Pedersen L, Pohl H, Baron J and Sorensen HT: Erosive reflux disease
increases risk for esophageal adenocarcinoma risk, compared with
non-erosive reflux. Clin Gastroenterol Hepatol. Jan 12–2012.(Epub
ahead of print).
|
|
38
|
Wu SR, Li CF, Hung LY, Huang AM, Tseng JT,
Tsou JH and Wang J: MCCAAT/enhancer-binding protein delta mediates
tumor necrosis factor alpha-induced Aurora kinase C transcription
and promotes genomic instability. J Biol Chem. 286:28662–28670.
2011. View Article : Google Scholar
|
|
39
|
Shakespear MR, Halili MA, Irvine KM,
Fairlie DP and Sweet MJ: Histone deacetylases as regulators of
inflammation and immunity. Trends Immunol. 32:335–343. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Berger J and Bird A: Role of MBD2 in gene
regulation and tumorigenesis. Biochem Soc Trans. 33:1537–1540.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fujita H, Fujii R, Aratani S, Amano T,
Fukamizu A and Nakajima T: Antithetic effects of MBD2a on gene
regulation. Mol Cell Biol. 23:2645–2657. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Müller-Tidow C, Kügler K, Diederichs S, et
al: Loss of expression of HDAC-recruiting methyl-CpG-binding domain
proteins in human cancer. Br J Cancer. 85:1168–1174.
2001.PubMed/NCBI
|
|
43
|
Kanai Y, Ushijima S, Nakanishi Y and
Hirohashi S: Reduced mRNA expression of the DNA demethylase, MBD2,
in human colorectal and stomach cancers. Biochem Biophys Res
Commun. 2:962–966. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chen ZP, Gu DS, Zhou ZP, et al: Decreased
expression of MBD2 and MBD4 gene and genomic-wide hypomethylation
in patients with primary immune thrombocytopenia. Hum Immunol.
72:486–491. 2011. View Article : Google Scholar : PubMed/NCBI
|
